Carbohydrate-to-Insulin Ratio in a Mediterranean Population of Type 1 Diabetic Patients on Continuous Subcutaneous Insulin Infusion Therapy

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2014 Dec 19

PMID 25519294

Citations 4

Authors

Valeria Alcantara-Aragon

Cintia Gonzalez

Rosa Corcoy

Justa Ubeda

Ana Chico

Affiliations

Soon will be listed here.

Abstract

Background: The carbohydrate-to-insulin ratio (CIR) is initially calculated from the total daily insulin dose (TDID). However, CIR likely presents variations owing to different population characteristics and intraday variations not being taken into account by most formulas. No information is available concerning the Mediterranean population. We investigated the CIR used by patients with type 1 diabetes (T1DM) using continuous subcutaneous insulin infusion (CSII) therapy in a Mediterranean area, to identify possible intraday variations and establish an adequate formula to calculate CIR.

Methods: Data from 170 T1DM patients from Barcelona were obtained retrospectively from the Spanish National Registry of CSII Therapy (SNR-CSII). Theoretical CIR was calculated using the formula: 500 divided by TDID. This theoretical CIR was compared to the real CIR.

Results: The real CIR was also compared between main meals. Patients with HbA1c < 7% (n = 44) were considered a reference group for accurate bolus calculation and were analyzed as a subgroup. The real CIR used was 11.5 g/UI for breakfast, 12 g/UI for lunch, and 13.3 g/UI for dinner. CIR obtained by the 500/TDID formula for all meals was 15.5 g/UI. We obtained similar results for the group with HbA1c < 7%. The real CIR differed significantly from the theoretical CIR values and between breakfast and the other main meals (P < .005).

Conclusions: CIR in our population was significantly lower for breakfast than for other meals. CIR using the 500/TDID formula underestimated prandial insulin requirements. A calculation of 350/TDID for breakfast and 400/TDID for lunch and dinner would be more appropriate for this population.

Citing Articles

In-silico evaluation of an artificial pancreas achieving automatic glycemic control in patients with type 1 diabetes.

Liu W, Chen T, Liang B, Wang Y, Jin H Front Endocrinol (Lausanne). 2023; 14:1115436.

PMID: 36793281 PMC: 9922739. DOI: 10.3389/fendo.2023.1115436.

A Randomized Controlled Study of an Insulin Dosing Application That Uses Recognition and Meal Bolus Estimations.

Pankowska E, Ladyzynski P, Foltynski P, Mazurczak K J Diabetes Sci Technol. 2017; 11(1):43-49.

PMID: 28264177 PMC: 5375087. DOI: 10.1177/1932296816683409.

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

King A, Kuroda A, Matsuhisa M, Hobbs T Curr Diab Rep. 2016; 16(9):83.

PMID: 27457238 PMC: 4960276. DOI: 10.1007/s11892-016-0772-0.

Boluses in Insulin Therapy.

Ziegler R, Freckmann G, Heinemann L J Diabetes Sci Technol. 2016; 11(1):165-171.

PMID: 27271845 PMC: 5375062. DOI: 10.1177/1932296816653142.

References

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

Brazeau A, Mircescu H, Desjardins K, Leroux C, Strychar I, Ekoe J . Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes. Diabetes Res Clin Pract. 2012; 99(1):19-23. DOI: 10.1016/j.diabres.2012.10.024. View

Kuroda A, Yasuda T, Takahara M, Sakamoto F, Kasami R, Miyashita K . Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump. Diabetes Technol Ther. 2012; 14(11):1077-80. DOI: 10.1089/dia.2012.0109. View

Karges B, Rosenbauer J, Kapellen T, Wagner V, Schober E, Karges W . Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med. 2014; 11(10):e1001742. PMC: 4188517. DOI: 10.1371/journal.pmed.1001742. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Ziegler R, Cavan D, Cranston I, Barnard K, Ryder J, Vogel C . Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36(11):3613-9. PMC: 3816874. DOI: 10.2337/dc13-0251. View

Speight J, Amiel S, Bradley C, Heller S, Oliver L, Roberts S . Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes. Diabetes Res Clin Pract. 2010; 89(1):22-9. DOI: 10.1016/j.diabres.2010.03.017. View

Walsh J, Roberts R, Bailey T . Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol. 2010; 4(5):1174-81. PMC: 2956816. DOI: 10.1177/193229681000400516. View

King A . Continuous glucose monitoring-guided insulin dosing in pump-treated patients with type 1 diabetes: a clinical guide. J Diabetes Sci Technol. 2012; 6(1):191-203. PMC: 3320838. DOI: 10.1177/193229681200600124. View

10.

Ziegler R, Tubili C, Chico A, Guerci B, Lundberg E, Borchert M . ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems. Diabetes Technol Ther. 2013; 15(9):738-43. DOI: 10.1089/dia.2013.0090. View

11.

Rabasa-Lhoret R, Garon J, Langelier H, Poisson D, Chiasson J . Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care. 1999; 22(5):667-73. DOI: 10.2337/diacare.22.5.667. View

12.

Plavsic L, Mitrovic K, Todorovic S, Vukovic R, Milenkovic T, Zdravkovic D . Glycaemic control and prevalence of hypoglycaemic events in children and adolescents with type 1 diabetes mellitus treated with insulin analogues. Vojnosanit Pregl. 2014; 71(9):817-20. View

13.

Ahola A, Makimattila S, Saraheimo M, Mikkila V, Forsblom C, Freese R . Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes. 2010; 2(3):194-202. DOI: 10.1111/j.1753-0407.2010.00086.x. View

14.

Lipska K, Warton E, Huang E, Moffet H, Inzucchi S, Krumholz H . HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013; 36(11):3535-42. PMC: 3816866. DOI: 10.2337/dc13-0610. View

15.

King A, Armstrong D . A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing. J Diabetes Sci Technol. 2009; 1(1):42-6. PMC: 2769601. DOI: 10.1177/193229680700100107. View

16.

Walsh J, Roberts R, Bailey T . Guidelines for optimal bolus calculator settings in adults. J Diabetes Sci Technol. 2011; 5(1):129-35. PMC: 3045234. DOI: 10.1177/193229681100500118. View

17.

Davidson P, Hebblewhite H, Steed R, Bode B . Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2009; 14(9):1095-101. DOI: 10.4158/EP.14.9.1095. View

18.

Scavone G, Manto A, Pitocco D, Gagliardi L, Caputo S, Mancini L . Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study. Diabet Med. 2010; 27(4):477-9. DOI: 10.1111/j.1464-5491.2010.02963.x. View